1 Harris WS, Mozaffarian D, Rimm E, et al. (2009) Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 119, 902–907.
2 Harris WS (2008) Linoleic acid and coronary heart disease. Prostaglandins Leukot Essent Fatty Acids 79, 169–171.
3 Czernichow S, Thomas D & Bruckert E (2010) n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations. Br J Nutr 104, 1–9.
4 Kris-Etherton P & Harris WS (2009) Dietary omega-6 polyunsaturated fatty acids – important for heart health. Clin Nutr Insight 35, 1–5.
5 Kris-Etherton P, Fleming J & Harris WS (2010) The debate about n-6 polyunsaturated fatty acid recommendations for cardiovascular health. J Am Diet Assoc 110, 201–204.
6 Gordon D (1995) Lowering cholesterol and total mortality. In Lowering Cholesterol in High Risk Individuals and Populations, pp. 33–48 [Rifkin BM, editor]. New York: Marcel Dekker, Inc.
7 Mozaffarian D, Micha R & Wallace S (2010) Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 7, e1000252.
8 Katan MB (2009) Omega-6 polyunsaturated fatty acids and coronary heart disease. Am J Clin Nutr 89, 1283–1284.
10 Ramsden CE, Hibbeln JR, Lands WE (2008) Letter to the Editor re: Linoleic acid and coronary heart disease. Prostaglandins Leukot Essent Fatty Acids, by ; 80, (1): 77; author reply-8.
11 Ramsden CE, Faurot KR, Carrera-Bastos P, et al. (2009) Dietary fat quality and coronary heart disease prevention: a unified theory based on evolutionary, historical, global and modern perspectives. Curr Treat Options Cardiovasc Med 11, 289–301.
12 Katan MB, Brouwer IA, Clarke R, et al. (2010) Saturated fat and heart disease. Am J Clin Nutr 92, 459–460.
13 Turpeinen O (1968) Diet and coronary events. J Am Diet Assoc 52, 209–213.
14 Turpeinen O (1979) Effect of cholesterol-lowering diet on mortality from coronary heart disease and other causes. Circulation 59, 1–7.
15 Turpeinen O, Miettinen M, Karvonen MJ, et al. (1968) Dietary prevention of coronary heart disease: long-term experiment. I. Observations on male subjects. Am J Clin Nutr 21, 255–276.
16 Miettinen M, Turpeinen O, Karvonen MJ, et al. (1972) Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women. Lancet 2, 835–838.
17 Miettinen M, Turpeinen O, Karvonen MJ, et al. (1983) Dietary prevention of coronary heart disease in women: the Finnish Mental Hospital Study. Int J Epidemiol 12, 17–25.
18 Burr ML, Fehily AM, Gilbert JF, et al. (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet ii, 757–761.
19 Burr ML, Fehily AM, Rogers S, et al. (1989) Diet and reinfarction trial (DART): design, recruitment, and compliance. Eur Heart J 10, 558–567.
20 Fehily AM, Vaughan-Williams E, Shiels K, et al. (1991) Factors influencing compliance with dietary advice: the Diet and Reinfarction Trial (DART). J Hum Nutr Diet 4, 33–42.
21 Burr ML (2001) Reflections on the Diet and Reinfarction Trial (DART). Eur Heart J 3, D75–D78.
22 Turpeinen O, Karvonen MJ, Pekkarinen M, et al. (1979) Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study. Int J Epidemiol 8, 99–118.
23 Reilly JG, Ayis SA, Ferrier IN, et al. (2002) Thioridazine and sudden unexplained death in psychiatric in-patients. Br J Psychiatry 180, 515–522.
24 Thornton CC & Wendkos MH (1971) EKG T-wave distortions among thioridazine-treated psychiatric inpatients (some correlates of the incidence and severity). Dis Nerv Syst 32, 320–323.
25 Rouleau F, Asfar P, Boulet S, et al. (2001) Transient ST segment elevation in right precordial leads induced by psychotropic drugs: relationship to the Brugada syndrome. J Cardiovasc Electrophysiol 12, 61–65.
26 Lipscomb PA (1980) Cardiovascular side effects of phenothiazines and tricyclic antidepressants. A review with precautionary measures. Postgrad Med 67, 189–192, .
27 Allison DB, Mentore JL, Heo M, et al. (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156, 1686–1696.
28 Fehily AM, Vaughan-Williams E, Shiels K, et al. (1989) The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART). J Hum Nutr Diet 2, 225–235.
30 Borenstein M, Hedges L, Higgins J, et al. (2006) .
31 Leren P (1970) The Oslo Diet-Heart Study. Eleven-year report. Circulation 42, 935–942.
32 Leren P (1966) The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Med Scand Suppl 466, 1–92.
33 Watts GF, Lewis B, Brunt JN, et al. (1992) Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 339, 563–569.
34 Watts GF, Jackson P, Burke V, et al. (1996) Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr 64, 202–209.
35 Medical Research Council (1968) Controlled trial of soya-bean oil in myocardial infarction. Lancet ii, 693–699.
36 Hiscock E, Dayton S, Pearce ML, et al. (1962) A palatable diet high in unsaturated fat. J Am Diet Assoc 40, 427–431.
37 Rose GA, Thomson WB & Williams RT (1965) Corn oil in treatment of ischaemic heart disease. Br Med J 1, 1531–1533.
38 Woodhill JM, Palmer AJ, Leelarthaepin B, et al. (1978) Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Adv Exp Med Biol 109, 317–330.
39 Frantz ID Jr, Dawson EA, Ashman PL, et al. (1989) Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey. Arteriosclerosis 9, 129–135.
40 Executive Committee on Diet and Heart Disease (1968) . Chapter XVII: Faribault Second Study. Circulation 37–38, I.260–I.I74.
41 Clarke JAC, Hedley E, Marr JW, et al. (1969) Dietary aspects of a controlled trial of soya-bean oil in myocardial infarction. Int J Food Sci Nutr 23, 136–150.
43 Watts GF, Jackson P, Mandalia S, et al. (1994) Nutrient intake and progression of coronary artery disease. Am J Cardiol 73, 328–332.
44 Dayton S, Pearce ML, Hashimoto S, et al. (1962) A controlled clinical trial of a diet high in unsaturated fat. Preliminary observations. N Engl J Med 266, 1017–1023.
45 Significant Points from the Annual Report of Marrickville Holdings. .
46 Woodhill JM, Palmer AJ & Blacket RB (1969) Dietary habits and their modification in a coronary prevention programme for Australians. Food Technol Aust 21, 264–271.
47 Woodhill JM & Bernstein L (1973) Lowering serum cholesterol levels by dietary modification. A change in food habits, not a special diet. Med J Aust 1, 973–979.
48 Blacket RB, Woodhill J & Mishkel MA (1965) Diet, hypercholesterolaemia and coronary heart disease. Med J Aust 1, 59–63.
49 Fisher M (1970) How the ‘Miracle’ was cowed: margarine quotas and politics. Aust Quart 42, 20–33.
50 Palmer J, Woodhill J & Blacket R (1969) Strict modified fat diet in coronary heart disease. The problem of nonresponders.. Isr J Med Sci 5, 754–759.
51 Fetcher ES, Foster N, Anderson JT, et al. (1967) Quantitative estimation of diets to control serum cholesterol. Am J Clin Nutr 20, 475–492.
52 Brewer ER, Ashman PL & Kuba K (1975) The Minnesota Coronary Survey: composition of their diets, adherence, and serum lipid response. Circulation , .
54 Frantz ID Jr .
55 Frantz ID (1971) .
56 Frantz ID (PI) (1967). .
57 Executive Committee on Diet and Heart Disease (1968) National Diet-Heart Study Report. Chapter IX: assessment of the diets. Circulation 37–38, I.125–I.I40.
58 Frantz ID Jr (1962) Notification and Statement of Grant Award: Diet and Heart Disease. New York: The Minnesota Governor's Council on Developmental Disabilities. http://www.mnddc.org/past/pdf-index.html. 59 Frantz ID Jr (1963) Summary Progress Report: Feasibility Study – Diet and Heart Disease (closed study at Faribault, Minnesota). New York: The Minnesota Governor's Council on Developmental Disabilities. http://www.mnddc.org/past/pdf-index.html.
60 Moore RB, Anderson JT, Taylor HL, et al. (1968) Effect of dietary fat on the fecal excretion of cholesterol and its degradation products in man. J Clin Invest 47, 1517–1534.
61 Begg CB & Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088–1101.
62 World Health Organization (2003) Diet, Nutrition and the Prevention of Chronic Diseases: Report of a Joint WHO/FAO Expert Consultation. . Geneva: WHO.
63 GISSI-Prevenzione Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354, 447–455.
64 Zittermann A & Koerfer R (2008) Vitamin D in the prevention and treatment of coronary heart disease. Curr Opin Clin Nutr Metab Care 11, 752–757.
65 Cantwell MM, Flynn MA & Gibney MJ (2006) Acute postprandial effect of hydrogenated fish oil, palm oil and lard on plasma cholesterol, triacylglycerol and non-esterified fatty acid metabolism in normocholesterolaemic males. Br J Nutr 95, 787–794.
66 Mozaffarian D, Aro A & Willett WC (2009) Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr 63, S5–S21.
67 Medical Research Council (1965) Low-fat diet in myocardial infarction: a controlled trial. Lancet ii, 501–504.
68 Frantz ID, Dawson EA, Kuba K, et al. (1975) The Minnesota Coronary Survey: effect of diet on cardiovascular events and deaths. American Heart Association Scientific Proceedings. Circulation 52, Suppl. 2, .
69 de Lorgeril M, Renaud S, Mamelle N, et al. (1994) Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343, 1454–1459.
70 Renaud S, de Lorgeril M, Delaye J, et al. (1995) Cretan Mediterranean diet for prevention of coronary heart disease.. Am J Clin Nutr 61, Suppl. 6, 1360S–1367S.
71 Simopoulos AP (2001) The Mediterranean diets: what is so special about the diet of Greece? The scientific evidence. J Nutr 131, Suppl. 11, 3065S–3073S.
72 de Lorgeril M, Salen P, Martin JL, et al. (1999) Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction – final report of the Lyon Diet Heart Study. Circulation 99, 779–785.
73 Begg CB & Berlin JA (1988) Publication bias – a problem in interpreting medical data. J R Statist Soc Series A – Statist Soc 151, 419–463.
74 Stern JM & Simes RJ (1997) Publication bias: evidence of delayed publication in a cohort study of clinical research projects. BMJ 315, 640–645.
75 Leren P (1968) Effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction – a controlled clinical trial. Bull N Y Acad Med 44, 1012–1020.
76 Dayton S, Chapman JM & Pearce ML, et al. (1970) Cholesterol, atherosclerosis, ischemic heart disease, and stroke. Ann Intern Med 72, 97–109.
77 Dayton S, Hashimoto S, Dixon W, et al. (1966) Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. J Lipid Res 7, 103–111.
78 Dayton S, Hashimoto S & Pearce ML (1965) Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation 32, 911–924.
79 Dayton S, Hashimoto S & Pearce ML (1967) Adipose tissue linoleic acid as a criterion of adherence to a modified diet. J Lipid Res 8, 508–510.
80 Dayton S & Pearce ML (1968) Trial of unsaturated-fat diet. Lancet ii, 1296–1297.
81 Dayton S & Pearce ML (1969) Diet high in unsaturated fat. A controlled clinical trial. Minn Med 52, 1237–1242.
82 Dayton S & Pearce ML (1969) Prevention of coronary heart disease and other complications of arteriosclerosis by modified diet. Am J Med 46, 751–762.
83 Dayton S & Pearce ML (1970) Diet and atherosclerosis. Lancet i, 473–474.
84 Dayton S, Pearce ML, Goldman H, et al. (1968) Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet ii, 1060–1062.
85 Pearce ML & Dayton S (1971) Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet i, 464–467.
86 Burr ML & Fehily AM (1991) Fatty fish and heart disease: a randomized controlled trial. World Rev Nutr Diet 66, 306–312.
87 Woodhill JM, Leelarthaepin B, Blacket RB, et al. (1975) Efficacy of weight reduction and carbohydrate restriction in moderate type 4 hyperlipidaemia. Cardiac Soc Aust N Z 5, 488.
88 Mozaffarian D & Clarke R (2009) Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr 63, Suppl. 2, S22–S33.
90 USDA (2006) .
91 Greaves JP & Hollingsworth DF (1966) Trends in food consumption in the United Kingdom. World Rev Nutr Diet 6, 34–89.
92 Ostlund RE Jr, Racette SB, Okeke A, et al. (2002) Phytosterols that are naturally present in commercial corn oil significantly reduce cholesterol absorption in humans. Am J Clin Nutr 75, 1000–1004.
93 Almendingen K, Jordal O, Kierulf P, et al. (1995) Effects of partially hydrogenated fish-oil, partially hydrogenated soybean oil, and butter on serum-lipoproteins and Lp[a] in men. J Lipid Res 36, 1370–1384.
94 Enig MG, Atal S, Keeney M, et al. (1990) Isomeric trans fatty acids in the U.S. diet. J Am Coll Nutr 9, 471–486.
95 Roberts DC (1991) Dietary factors in the fall in coronary heart disease mortality. Prostaglandins Leukot Essent Fatty Acids 44, 97–101.
96 OECD (1954–1985) Food Consumption Statistics. Paris: Organisation for Economic Cooperation and Development.